![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CLDN10-AS1 |
Gene summary for CLDN10-AS1 |
![]() |
Gene information | Species | Human | Gene symbol | CLDN10-AS1 | Gene ID | 100874194 |
Gene name | CLDN10 antisense RNA 1 | |
Gene Alias | CLDN10-AS1 | |
Cytomap | 13q32.1 | |
Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
100874194 | CLDN10-AS1 | RNA-P17T-P17T-2 | Human | Lung | IAC | 1.99e-06 | 7.03e-01 | 0.3371 |
100874194 | CLDN10-AS1 | RNA-P17T-P17T-4 | Human | Lung | IAC | 1.13e-06 | 8.20e-01 | 0.343 |
100874194 | CLDN10-AS1 | RNA-P17T-P17T-6 | Human | Lung | IAC | 1.13e-06 | 7.66e-01 | 0.3385 |
100874194 | CLDN10-AS1 | RNA-P17T-P17T-8 | Human | Lung | IAC | 5.26e-09 | 7.58e-01 | 0.3329 |
100874194 | CLDN10-AS1 | RNA-P18T-P18T-2 | Human | Lung | IAC | 1.16e-02 | 9.25e-01 | 0.1129 |
100874194 | CLDN10-AS1 | RNA-P18T-P18T-6 | Human | Lung | IAC | 1.73e-02 | 8.69e-01 | 0.0856 |
100874194 | CLDN10-AS1 | RNA-P18T-P18T-8 | Human | Lung | IAC | 7.36e-03 | 1.02e+00 | 0.1151 |
100874194 | CLDN10-AS1 | RNA-P3T-P3T-1 | Human | Lung | IAC | 1.60e-12 | 8.16e-01 | 0.1829 |
100874194 | CLDN10-AS1 | RNA-P3T-P3T-2 | Human | Lung | IAC | 4.78e-13 | 8.01e-01 | 0.1835 |
100874194 | CLDN10-AS1 | RNA-P3T-P3T-4 | Human | Lung | IAC | 1.04e-14 | 8.21e-01 | 0.1859 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Lung | ![]() | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ | ||
IAC: Invasive lung adenocarcinoma | ||
MIA: Minimally invasive adenocarcinoma |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Oral cavity | OSCC | ![]() |
Oral cavity | LP | ![]() |
Oral cavity | EOLP | ![]() |
Oral cavity | NEOLP | ![]() |
Esophagus | HGIN | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |